Latest news
InnoCan Pharma's August Crossroads: A Rebrand Vote, a Consumer Milestone, and the Cost of Waiting - AD HOC NEWSAD HOC NEWS · Sat, 08 Aug 2026 14:55:07 GMTInnoCan Pharma Stock Surges 13.64% as Drug-Delivery Innovation and Pharmaceutical Growth Potential Attract Investor Interest - kalkine.cakalkine.ca · Fri, 07 Aug 2026 14:26:00 GMTInnoCan Pharma's Balancing Act: US Listing Hopes, Geopolitical Headwinds, and a Wellness Engine - AD HOC NEWSAD HOC NEWS · Thu, 06 Aug 2026 03:40:55 GMTInnoCan Pharma's Dual Narrative: A Wellness Milestone Arrives While the SEC Clock Keeps Ticking - AD HOC NEWSAD HOC NEWS · Thu, 06 Aug 2026 00:32:48 GMTInnoCan Pharma's Waiting Game: SEC Review Drags On as Consumer Arm Hits New Milestones - AD HOC NEWSAD HOC NEWS · Thu, 06 Aug 2026 00:31:07 GMTOver 100,000 Positive Verified Customer Reviews Reflect Growing Consumer Trust - PR NewswirePR Newswire · Wed, 05 Aug 2026 13:30:00 GMTInnoCan Pharma Corporation (CN:INNO) Extends Losses as Weak Sentiment and Market Uncertainty Pressure Shares - kalkine.cakalkine.ca · Wed, 05 Aug 2026 09:31:00 GMTInnoCan Pharma's Wellness Engine Hits 2 Million Customers as Shareholders Prepare for a Defining Vot - AD HOC NEWSAD HOC NEWS · Wed, 05 Aug 2026 04:41:36 GMT